Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Buy
62
MLSS Quote, Financials, Valuation and Earnings
Last price:
$0.96
Seasonality move
:
15.65%
Day range:
$0.93 - $1.00
52-week range:
$0.52 - $1.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.30x
P/B ratio:
10.14x
Volume:
72.8K
Avg. volume:
203.9K
1-year change:
42.44%
Market cap:
$73.2M
Revenue:
$9.8M
EPS (TTM):
-$0.07
Analysts' Opinion
-
Consensus RatingMilestone Scientific has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Milestone Scientific has an estimated upside of 126.04% from its current price of $0.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.94.
Fair Value
-
According to the consensus of 0 analysts, Milestone Scientific has 126.04% upside to fair value with a price target of -- per share.
MLSS vs. S&P 500
-
Over the past 5 trading days, Milestone Scientific has overperformed the S&P 500 by 12.53% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Milestone Scientific does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Milestone Scientific has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Milestone Scientific reported revenues of $2.5M.
Earnings Growth
-
Milestone Scientific has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Milestone Scientific reported earnings per share of -$0.02.
Enterprise value:
68.5M
EV / Invested capital:
--
Price / LTM sales:
8.30x
EV / EBIT:
--
EV / Revenue:
7.71x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-25.69x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$6.4M
Return On Assets:
-40.87%
Net Income Margin (TTM):
-52.01%
Return On Equity:
-61.33%
Return On Invested Capital:
-61.33%
Operating Margin:
-58.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $9.4M | $9.8M | $8.9M | $2.1M | $2.5M | |
| Gross Profit | $5.6M | $6.4M | $6.4M | $1.5M | $1.8M | |
| Operating Income | -$8.4M | -$7.1M | -$6.7M | -$1.5M | -$1.5M | |
| EBITDA | -$8.2M | -$7M | -$6.6M | -$1.5M | -$1.4M | |
| Diluted EPS | -$0.12 | -$0.09 | -$0.07 | -$0.02 | -$0.02 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $18.9M | $19.2M | $14.5M | $10M | $10.7M | |
| Total Assets | $19.9M | $20.1M | $15.3M | $10.6M | $11.2M | |
| Current Liabilities | $3.5M | $3.5M | $3.7M | $3.3M | $3.8M | |
| Total Liabilities | $4.1M | $4M | $4.1M | $3.6M | $4M | |
| Total Equity | $15.8M | $16M | $11.2M | $7M | $7.2M | |
| Total Debt | $276.2K | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$5.3M | -$5.2M | -$2.7M | -$1.1M | -$973.9K | |
| Cash From Investing | $500 | -$2.5M | $2.5M | -$475.5K | -- | |
| Cash From Financing | $667.5K | -$8.5K | $2.8M | -$2.2K | -$2.6K | |
| Free Cash Flow | -$5.3M | -$5.2M | -$2.7M | -$1.1M | -$973.9K | |
MLSS
Sector
Market Cap
$73.2M
$48.6M
Price % of 52-Week High
85.46%
47.39%
Dividend Yield
0%
0%
Shareholder Yield
-3.91%
-0.74%
1-Year Price Total Return
42.44%
-33.25%
Beta (5-Year)
1.096
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$0.90
200-day SMA
Buy
Level
$0.80
Bollinger Bands (100)
Buy
Level
0.78 - 0.98
Chaikin Money Flow
Buy
Level
4.8M
20-day SMA
Buy
Level
$0.86
Relative Strength Index (RSI14)
Buy
Level
57.82
ADX Line
Buy
Level
31.29
Williams %R
Neutral
Level
-25.0104
50-day SMA
Buy
Level
$0.82
MACD (12, 26)
Buy
Level
0.03
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
59M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.2215)
Sell
CA Score
(Annual)
Level (-1.6688)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (5.4769)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Stock Forecast FAQ
In the current month, MLSS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MLSS average analyst price target in the past 3 months is --.
-
Where Will Milestone Scientific Stock Be In 1 Year?
According to analysts, the consensus estimate is that Milestone Scientific share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Milestone Scientific?
Analysts are divided on their view about Milestone Scientific share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Milestone Scientific is a Sell and believe this share price will drop from its current level to --.
-
What Is Milestone Scientific's Price Target?
The price target for Milestone Scientific over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MLSS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Milestone Scientific is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MLSS?
You can purchase shares of Milestone Scientific via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Milestone Scientific shares.
-
What Is The Milestone Scientific Share Price Today?
Milestone Scientific was last trading at $0.96 per share. This represents the most recent stock quote for Milestone Scientific. Yesterday, Milestone Scientific closed at $0.94 per share.
-
How To Buy Milestone Scientific Stock Online?
In order to purchase Milestone Scientific stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 3
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
88
BMA alert for Jan 3
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
50
AGFY alert for Jan 3
Agrify [AGFY] is down 5.86% over the past day.
